{
  "ticker": "ABCL",
  "success": true,
  "price": {
    "current": 3.86,
    "currency": "USD",
    "day_high": 3.91,
    "day_low": 3.75,
    "52_week_high": 6.515,
    "52_week_low": 1.891
  },
  "market_cap": {
    "value": 1155433216.0,
    "currency": "USD"
  },
  "shares_outstanding": 299335048.0,
  "volume": {
    "last": 2423245,
    "average_30d": 4878478
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -5.594203,
    "price_to_book": 1.1972704
  },
  "company_info": {
    "name": "AbCellera Biologics Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 1355992000.0,
    "total_liabilities": 391954000.0,
    "stockholders_equity": 964038000.0,
    "cash": 83159000.0,
    "marketable_securities": 412513000.0,
    "total_liquidity": 495672000.0,
    "total_debt": 142218000.0,
    "long_term_debt": 137052000.0,
    "current_debt": 5166000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:29:09.097911",
    "url": "https://finance.yahoo.com/quote/ABCL",
    "data_hash": "7f0268d5bd5e59b7"
  }
}